Empirical Finance’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.38M | Buy |
73,052
+440
| +0.6% | +$20.4K | 0.18% | 116 |
|
2025
Q1 | $4.43M | Buy |
72,612
+1,009
| +1% | +$61.5K | 0.27% | 82 |
|
2024
Q4 | $4.05M | Sell |
71,603
-1,073
| -1% | -$60.7K | 0.23% | 82 |
|
2024
Q3 | $3.76M | Buy |
72,676
+1,366
| +2% | +$70.7K | 0.22% | 92 |
|
2024
Q2 | $2.96M | Sell |
71,310
-5,932
| -8% | -$246K | 0.19% | 104 |
|
2024
Q1 | $4.19M | Buy |
77,242
+2,429
| +3% | +$132K | 0.26% | 84 |
|
2023
Q4 | $3.84M | Buy |
74,813
+94
| +0.1% | +$4.82K | 0.27% | 81 |
|
2023
Q3 | $4.34M | Buy |
74,719
+6,375
| +9% | +$370K | 0.32% | 62 |
|
2023
Q2 | $4.37M | Buy |
68,344
+7,615
| +13% | +$487K | 0.34% | 61 |
|
2023
Q1 | $4.21M | Buy |
60,729
+2,994
| +5% | +$208K | 0.39% | 53 |
|
2022
Q4 | $4.15M | Buy |
57,735
+4,392
| +8% | +$316K | 0.43% | 48 |
|
2022
Q3 | $3.79M | Buy |
53,343
+8,207
| +18% | +$583K | 0.45% | 45 |
|
2022
Q2 | $3.48M | Buy |
45,136
+2,340
| +5% | +$180K | 0.44% | 45 |
|
2022
Q1 | $3.13M | Buy |
42,796
+4,644
| +12% | +$339K | 0.35% | 58 |
|
2021
Q4 | $2.38M | Buy |
38,152
+10,041
| +36% | +$626K | 0.28% | 67 |
|
2021
Q3 | $1.66M | Buy |
28,111
+1,560
| +6% | +$92.3K | 0.25% | 76 |
|
2021
Q2 | $1.77M | Buy |
26,551
+3,670
| +16% | +$245K | 0.29% | 66 |
|
2021
Q1 | $1.42M | Hold |
22,881
| – | – | 0.25% | 104 |
|
2020
Q4 | $1.42M | Buy |
22,881
+4,025
| +21% | +$250K | 0.25% | 104 |
|
2020
Q3 | $1.14M | Buy |
18,856
+4,398
| +30% | +$265K | 0.24% | 107 |
|
2020
Q2 | $850K | Buy |
14,458
+1,984
| +16% | +$117K | 0.22% | 113 |
|
2020
Q1 | $695K | Buy |
12,474
+4,939
| +66% | +$275K | 0.22% | 106 |
|
2019
Q4 | $484K | Buy |
+7,535
| New | +$484K | 0.12% | 140 |
|
2017
Q1 | – | Sell |
-727
| Closed | -$43K | – | 149 |
|
2016
Q4 | $43K | Buy |
+727
| New | +$43K | 0.03% | 113 |
|